fibclot 1.5 g
laboratoire francais du fractionnement et des biotechnologies - humanfibrinogen - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 1.5 g
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragika - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
carbidopa/levodopa fair-med 12.5 mg / 50 mg
fair-med healthcare gmbh - karbidopamonohydrat / levodopa - tablett - 12.5 mg / 50 mg
carbidopa/levodopa fair-med 25 mg / 100 mg
fair-med healthcare gmbh - karbidopamonohydrat / levodopa - tablett - 25 mg / 100 mg
lamictal 200 mg
glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 200 mg
lamictal 2 mg
glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 2 mg
lamictal 5 mg
glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 5 mg
lamictal 25 mg
glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 25 mg
lamictal 50 mg
glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 50 mg